{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:33:31Z","timestamp":1791275611201,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T00:00:00Z","timestamp":1298332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1007\/s00277-011-1184-5","type":"journal-article","created":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T11:04:23Z","timestamp":1298286263000},"page":"1031-1036","source":"Crossref","is-referenced-by-count":4,"title":["Anti-annexin V IgG and IgM antibodies in sickle cell disease patients with vaso-occlusive crisis"],"prefix":"10.1007","volume":"90","author":[{"given":"Mai S.","family":"Sater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najat","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman K.","family":"Al-Absi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer M.","family":"Al-Subaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Al-Ola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim Y.","family":"Almawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,22]]},"reference":[{"key":"1184_CR1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MOH.0b013e328329e167","volume":"16","author":"JJ Field","year":"2009","unstructured":"Field JJ, Knight-Perry JE, Debaun MR (2009) Acute pain in children and adults with sickle cell disease: management in the absence of evidence-based guidelines. Curr Opin Hematol 16:173\u2013178","journal-title":"Curr Opin Hematol"},{"key":"1184_CR2","first-page":"373","volume":"26","author":"LD Jakubik","year":"2000","unstructured":"Jakubik LD, Thompson M (2000) Care of the child with sickle cell disease: acute complications. Pediatr Nurs 26:373\u2013379","journal-title":"Pediatr Nurs"},{"key":"1184_CR3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.hoc.2005.08.002","volume":"19","author":"EY Chiang","year":"2005","unstructured":"Chiang EY, Frenette PS (2005) Sickle cell vaso-occlusion. Hematol Oncol Clin North Am 19:771\u2013784","journal-title":"Hematol Oncol Clin North Am"},{"issue":"Suppl 1","key":"1184_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/10245330512331390069","volume":"10","author":"A Kutlar","year":"2005","unstructured":"Kutlar A (2005) Sickle cell disease: a multigenic perspective of a single gene disorder. Hematology 10(Suppl 1):92\u201399","journal-title":"Hematology"},{"key":"1184_CR5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood.V68.5.1162.1162","volume":"68","author":"DK Kaul","year":"1986","unstructured":"Kaul DK, Fabry ME, Nagel RL (1986) Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells. Blood 68:1162\u20131166","journal-title":"Blood"},{"key":"1184_CR6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/ajh.10145","volume":"70","author":"RA Montes","year":"2002","unstructured":"Montes RA, Eckman JR, Hsu LL, Wick TM (2002) Sickle erythrocyte adherence to endothelium at low shear: role of shear stress in propagation of vaso-occlusion. Am J Hematol 70:216\u2013227","journal-title":"Am J Hematol"},{"key":"1184_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","volume":"9","author":"PS Frenette","year":"2002","unstructured":"Frenette PS (2002) Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol 9:101\u2013106","journal-title":"Curr Opin Hematol"},{"key":"1184_CR8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.amjmed.2003.07.011","volume":"115","author":"KI Ataga","year":"2003","unstructured":"Ataga KI, Orringer EP (2003) Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 115:721\u2013728","journal-title":"Am J Med"},{"key":"1184_CR9","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1073\/pnas.0409876102","volume":"102","author":"JR Pawloski","year":"2005","unstructured":"Pawloski JR, Hess DT, Stamler JS (2005) Impaired vasodilation by red blood cells in sickle cell disease. Proc Natl Acad Sci USA 102:2531\u20132536","journal-title":"Proc Natl Acad Sci USA"},{"key":"1184_CR10","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1182\/blood.V98.12.3228","volume":"98","author":"BN Setty","year":"2001","unstructured":"Setty BN, Rao AK, Stuart MJ (2001) Thrombophilia in sickle cell disease: the red cell connection. Blood 98:3228\u20133233","journal-title":"Blood"},{"key":"1184_CR11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00282-996-0279-2","volume":"38","author":"B Nsiri","year":"1996","unstructured":"Nsiri B, Gritli N, Bayoudh F, Messaoud T, Fattoum S, Machghoul S (1996) Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease. Hematol Cell Ther 38:279\u2013284","journal-title":"Hematol Cell Ther"},{"key":"1184_CR12","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2003-03-0693","volume":"102","author":"AS Shet","year":"2003","unstructured":"Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP (2003) Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 102:2678\u20132683","journal-title":"Blood"},{"key":"1184_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.mbc.0000164431.98169.8f","volume":"16","author":"JS Mohan","year":"2005","unstructured":"Mohan JS, Lip GY, Wright J, Bareford D, Blann AD (2005) Plasma levels of tissue factor and soluble E-selectin in sickle cell disease: relationship to genotype and to inflammation. Blood Coagul Fibrinolysis 16:209\u2013214","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1184_CR14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2362.2006.01698.x","volume":"36","author":"AM Galan","year":"2006","unstructured":"Galan AM, van Heerde WL, Escolar G, Ordinas A, Sixma J, de Groot PG (2006) Antithrombotic action of annexin V proved as efficient as direct inhibition of tissue factor or thrombin. Eur J Clin Investig 36:633\u2013639","journal-title":"Eur J Clin Investig"},{"key":"1184_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2004.07.006","volume":"4","author":"G Esposito","year":"2005","unstructured":"Esposito G, Tamby MC, Chanseaud Y, Servettaz A, Guillevin L, Mouthon L (2005) Anti-annexin V antibodies: are they prothrombotic? Autoimmun Rev 4:55\u201360","journal-title":"Autoimmun Rev"},{"key":"1184_CR16","first-page":"924","volume":"27","author":"G Lakos","year":"2000","unstructured":"1Lakos G, Kiss E, Regeczy N, Tarjan P, Soltesz P, Zeher M, Bodolay E, Szucs G, Szakony S, Sipka S, Szegedi G (2000) Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. J Rheumatol 27:924\u2013929","journal-title":"J Rheumatol"},{"key":"1184_CR17","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/clinchem\/47.6.1008","volume":"47","author":"J Nojima","year":"2001","unstructured":"Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Iwatani Y, Kanakura Y (2001) Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Clin Chem 47:1008\u20131015","journal-title":"Clin Chem"},{"key":"1184_CR18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","volume":"137","author":"A Tomer","year":"2001","unstructured":"Tomer A, Harker LA, Kasey S, Eckman JR (2001) Thrombogenesis in sickle cell disease. J Lab Clin Med 137:398\u2013407","journal-title":"J Lab Clin Med"},{"key":"1184_CR19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0037-1613209","volume":"88","author":"JW Heemskerk","year":"2002","unstructured":"Heemskerk JW, Bevers EM, Lindhout T (2002) Platelet activation and blood coagulation. Thromb Haemost 88:186\u2013193","journal-title":"Thromb Haemost"},{"key":"1184_CR20","doi-asserted-by":"crossref","first-page":"H1679","DOI":"10.1152\/ajpheart.00256.2006","volume":"291","author":"J Haynes Jr","year":"2006","unstructured":"Haynes J Jr, Obiako B, King JA, Hester RB, Ofori-Acquah S (2006) Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. Am J Physiol Heart Circ Physiol 291:H1679\u2013H1685","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1184_CR21","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1074\/jbc.M411710200","volume":"280","author":"S Ravassa","year":"2005","unstructured":"Ravassa S, Bennaghmouch A, Kenis H, Lindhout T, Hackeng T, Narula J, Hofstra L, Reutelingsperger C (2005) Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoire. J Biol Chem 280:6028\u20136035","journal-title":"J Biol Chem"},{"key":"1184_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1432-1033.1988.tb13981.x","volume":"173","author":"CP Reutelingsperger","year":"1988","unstructured":"Reutelingsperger CP, Kop JM, Hornstra G, Hemker HC (1988) Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids. Eur J Biochem 173:171\u2013178","journal-title":"Eur J Biochem"},{"key":"1184_CR23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jb\/mvh071","volume":"135","author":"M Ida","year":"2004","unstructured":"Ida M, Satoh A, Matsumoto I, Kojima-Aikawa K (2004) Human annexin V binds to sulfatide: contribution to regulation of blood coagulation. J Biochem Tokyo 135:583\u2013588","journal-title":"J Biochem Tokyo"},{"key":"1184_CR24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/ard.51.5.671","volume":"51","author":"K Ceulaer De","year":"1992","unstructured":"De Ceulaer K, Khamashta MA, Harris EN, Serjeant GR, Hughes GR (1992) Anti-phospholipid antibodies in homozygous sickle cell disease. Ann Rheum Dis 51:671\u2013672","journal-title":"Ann Rheum Dis"},{"key":"1184_CR25","first-page":"291","volume":"62","author":"A Diatta","year":"2004","unstructured":"Diatta A, Toure-Fall AO, Sarr NG, Diallo F, Diagne I, Lopez-Sall P, Wone I, Vassauft A, Sall ND, Thiam D, Toure M (2004) Prevalence of antiphospholipid antibodies in patients with sickle cell disease. Ann Biol Clin Paris 62:291\u2013294","journal-title":"Ann Biol Clin Paris"},{"key":"1184_CR26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1309\/298H-NLBU-E47G-8PYL","volume":"114","author":"H Ogawa","year":"2000","unstructured":"Ogawa H, Zhao D, Dlott JS, Cameron GS, Yamazaki M, Hata T, Triplett DA (2000) Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities. Am J Clin Pathol 114:619\u2013628","journal-title":"Am J Clin Pathol"},{"key":"1184_CR27","first-page":"1715","volume":"26","author":"A Satoh","year":"1999","unstructured":"Satoh A, Suzuki K, Takayama E, Kojima K, Hidaka T, Kawakami M, Matsumoto I, Ohsuzu F (1999) Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 26:1715\u20131720","journal-title":"J Rheumatol"},{"key":"1184_CR28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-5155(00)00300-2","volume":"45","author":"JR Smith","year":"2001","unstructured":"Smith JR, Chng H, Chee S (2001) Primary antiphospholipid syndrome masquerading as diabetic retinopathy. Jpn J Ophthalmol 45:105\u2013108","journal-title":"Jpn J Ophthalmol"},{"key":"1184_CR29","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood.V92.5.1652","volume":"92","author":"JH Rand","year":"1998","unstructured":"Rand JH, Wu XX, Andree HA, Ross JB, Rusinova E, Gascon-Lema MG, Calandri C, Harpel PC (1998) Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a \"lupus procoagulant\" phenomenon. Blood 92:1652\u20131660","journal-title":"Blood"},{"key":"1184_CR30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/pbc.20579","volume":"47","author":"LJ Raffini","year":"2006","unstructured":"Raffini LJ, Niebanck AE, Hrusovsky J, Stevens A, Blackwood-Chirchir A, Ohene-Frempong K, Kwiatkowski JL (2006) Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease. Pediatr Blood Cancer 47:589\u2013593","journal-title":"Pediatr Blood Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1184-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-011-1184-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-011-1184-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T19:16:51Z","timestamp":1592335011000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-011-1184-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,22]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["1184"],"URL":"https:\/\/doi.org\/10.1007\/s00277-011-1184-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,22]]}}}